πŸ‡ΊπŸ‡Έ FDA
Patent

US 9029546

Pyrazolopyridine kinase inhibitors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 9029546 (Pyrazolopyridine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/06, A61P17/06